VICH 6 Conference (February 27 & 28, 2019 in Cape Town, South Africa)

Session 1: Official Opening

• What is VICH, History and Objectives - Dr. H. Marion 
• What does the OIE see as the benefits of the VICH to OIE members - Dr. G. Brucker  

Session 2: Keynote Addresses

• What does an Outreach Forum member see as the benefits of VICH - Dr. S. Yunus
• The contribution of VICH to the Global One Health Approach - Focus on antimicrobial resistance - Dr. J-P. Orand
• Training benefits gained by Outreach Forum members - Dr. T. Huang-Fu

Session 3: Implementing VICH Guidelines

• BY VICH Observer - Dr. M.J. Ireland
• By VICH Member - Ms. B. Robinson
• Possible regulatory obstacles and perspectives in adopting VICH GLs in VOF countries/regions and how to overcome them - Dr. Y. Kosenko

Session 4: Voice of Industries

• Stimulating innovation - Dr. E. De Ridder
• Regulatory convergence - Dr. A. Böttner
• Animal Health Product availability and accessability - Dr. G. Agède

Session 5: Existing VICH GLs - Hot Topics

• Academia's view of the benefits of VICH - Prof. V. Naidoo
• VICH and the 3Rs - Dr. N. Jarrett
• Waiver of Target Animal Batch Safety Test - Dr. N. Nwankpa

Session 6: New VICH GLs

• Climatic Zone III / IV Stability Guideline - Prof. H. Leng
• Combination Products GL - Ms. B. Robinson
• New MRK GLs - Aquatic species and honey - Dr. S. Scheid

Session 7: African Regional Activities

• A public, private partnership to expedite product registrations - Ms. M. Churchill
• The Zazibona work sharing experience in the SADC region - Dr. Z. Makoni
• Pharmacovigilance - the East Africal electronic system of reporting - Dr. N. Aineplan

Session 8: Global Perspectives

• Regulatory perspective on global trends in veterinary biologics - Dr. B. Rippke
• Why global regulatory convergence is important - Dr. S. Thevasagayam

Session 9: Expectations for VICH

• VOF expectations - Dr. A. Teko-Agbo
• VICH and veterinary medicines availability - Improvement of global animal & human health - Dr. J. Lwoyero

Session 10: Vision for the future

• The vision for the future - Dr. M. Lucia

VICH 5 Conference (October 28 & 29, 2015 in Tokyo, Japan)

Session 1: Official Opening

• What is VICH, History and Objectives - Dr. Hervé Marion - VICH Secretariat
• The benefits of VICH to the VICH member countries & regions - Dr. Donald Prater - U.S. FDA

Session 2: Keynote Addresses

• The contribution of VICH to the global One Health approach - Dr. Jean-Pierre Orand - OIE
• The benefits of VICH to emerging countries - Dr. Sasi Jaroenpoj - Thailand/ASEAN
• The needs and expectations of a global industry - Mr. Carel du Marchie Sarvaas - HealthforAnimals
• VICH/OIE training strategy - Dr. Steven Vaughn - U.S. FDA

Session 3: How to use VICH guidelines


Session 4: Voice of Industries

• Trends in research and development of new veterinary drug substances and products - Dr. Mark Micallef - Zenoaq, Japan
• Benchmarking the Livestock Business Environment - Mrs. Edna Kallon - World Bank, USA

Session 5: Contribution to animal welfare in tests for VMPs

• Statement of principle for VICH the "3R" approach & Alternatives to Animal Testing - Dr. Nicholas Jarrett - EU/VICH EU coordinator
• Waiver of Target Animal Batch Safety Test - Dr. Marlies Halder - EU/Topic leader for TABST in the BQM EWG

Session 6: VICH NOW

• The VICH pharmacovigilance guidelines - Dr. Margarita Brown - FDA
• Bioequivalence - Dr. Marilyn Martinez - FDA

Session 7: Topics of particular interest for Observer Countries and VOF members

• Development of a VICH guideline on stability studies to address climatic zones III and IV - Dr. Alice Sigobodhla - Department of Health, South Africa
• New VICH guideline on residue studies in aquatic species - Dr. Pamela Boner - Zoetis/Topic leader for aquatic species in the MRK EWG
• New VICH guideline on the efficacy studies for combination products - Dr. Ken Noda - JMAFF

Session 8: Ongoing Activities: Global Perspectives

• Outcome of the HealthforAnimals 2015 Global Animal Health Conference - Dr. Bettye Walters - Center for Veterinary Medicine, U.S. FDA
• Regulatory perspective on trends in veterinary biologics - Dr. Byron Rippke - Center for Veterinary Biologics at USDA, APHIS, VS, CVB
• Why regulatory convergence is important - Mr. Samuel J. Thevasagayam - Bill & Melinda Gates Foundation

Session 9: Finale

• The expectations from VICH Outreach Forum members - Dr. Carlos Francia - CAPROVE
• VICH and veterinary medicines availability - improvement of global animal & human health - Dr. Jean-Pierre Orand - OIE
• The Vision for the future - Dr. Yuko Endo - NVAL, JMAFF

VICH 4 Conference (June 24 & 25, 2010 in Paris)

• VICH EWGs Posters (in pdf) - The posters exhibited during the conference are in the attachments
• Presentations
• Pictures of the conference

• IFAH Press Release: VICH reaches out to non-VICH regions
• Poster - VICH: History, Achievements and Future
• Poster - VICH: Steering Committee
• Poster - VICH Metabolism and Residue Kinetics EWG
• Poster - VICH Quality EWG
• Poster - VICH Efficacy (Anthelmintics) EWG
• Poster - VICH Safety EWG
• Poster - VICH Environmental Safety EWG
• Poster - VICH Microbiological ADI EWG
• Poster - VICH Pharmacovigilance EWG
• Poster - VICH Target Animal Safety EWG
• Poster - VICH Biologicals Quality Monitoring EWG